Loading...
Loading...
Browse all stories on DeepNewz
VisitMost utilized Med-Gemini model by healthcare providers in 2024
Med-Gemini-L 1.0 • 25%
Med-Gemini-M 1.0 • 25%
Med-Gemini-M 1.5 • 25%
Other • 25%
Sales data from Google or surveys of healthcare providers.
Google's Med-Gemini AI Scores 91.1% on USMLE, Outperforms GPT-4 by 44.5%
May 7, 2024, 02:16 AM
Google has introduced Med-Gemini, a new family of AI models developed by Google DeepMind, designed specifically for the medical field. These models, which build on the foundations of Gemini 1.0 and 1.5 LLMs, have demonstrated superior performance in healthcare AI, outperforming GPT-4 in 10 out of 14 tasks and achieving 44.5% better performance in certain benchmarks. Med-Gemini has been particularly noted for its ability to handle complex tasks within electronic health records and for achieving a 91.1% accuracy on the US Medical Licensing Exam (USMLE). The models include Med-Gemini-L 1.0, Med-Gemini-M 1.0, Med-Gemini-M 1.5, and have capabilities for 2D and 3D medical imaging, as well as genomic risk assessments, showcasing their potential to revolutionize medical diagnostics and clinical reasoning.
View original story
High adoption in diagnostics • 25%
High adoption in surgical assistance • 25%
High adoption in personalized medicine • 25%
Limited adoption across sectors • 25%
Oncology • 20%
Neurology • 20%
Cardiology • 20%
Radiology • 20%
General Practice • 20%
North America • 25%
Europe • 25%
Asia-Pacific • 25%
Rest of the World • 25%
Hospitals • 33%
Research Centers • 33%
Private Practices • 33%
0-2 new applications • 25%
3-5 new applications • 25%
6-8 new applications • 25%
More than 8 applications • 25%
Leads in all benchmarks • 33%
Leads in most benchmarks • 33%
Underperforms in most benchmarks • 34%
Medical Diagnostics • 25%
Surgical Assistance • 25%
Genomic Research • 25%
Health Record Analysis • 25%
1-2 partnerships • 33%
3-5 partnerships • 33%
More than 5 partnerships • 34%
No expansion • 25%
1-3 countries • 25%
4-6 countries • 25%
More than 6 countries • 25%